The Global Latex Agglutination Test Kits Market Size was Valued at USD 632.57 Million in 2023 and the Worldwide Latex Agglutination Test Kits Market Size is Expected to Reach USD 1083.41 Million by ...

Multiple Value-creating Catalysts Across the Annexon Portfolio Throughout 2024Pivotal Phase 3 Data for ANX005 in Guillain-Barré Syndrome (GBS) ...

Annison, E. F., and Morgan, W. T. J., Biochem. J. (in the press).

Cold agglutinin disease is under clinical development by NovelMed Therapeutics and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia. According to GlobalData, Phase I drugs for Acquired ...

Moreover, we performed immunofluorescence staining for the marker of the acrosome (peanut agglutinin: PNA) as well as the mitochondrial marker (Transcription Factor A, Mitochondrial: TFAM) to confirm ...

Moreover, we performed immunofluorescence staining for the marker of the acrosome (peanut agglutinin: PNA) as well as the mitochondrial marker (transcription factor A, mitochondrial: TFAM) to confirm ...

cold agglutinin disease and unspecified antibody-related neurological diseases. It is administered through intravenous and subcutaneous route. The drug candidate is an engineered B-cell modulator. It ...

Peter C. Nowell; Phytohemagglutinin: An Initiator of Mitosis in Cultures of Normal Human Leukocytes *. Cancer Res 1 May 1960; 20 (4): 462–466. Possible factors responsible for the initiation of ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Investigational therapies may soon change the treatment ...